In vitro multispecies Lubbock chronic wound biofilm model
暂无分享,去创建一个
Yan Sun | S. Dowd | D. Rhoads | Yan Sun | R. Wolcott | Scot E. Dowd | Ethan Smith | Dan D. Rhoads | Randall D. Wolcott | E. Smith
[1] P. Stewart,et al. Biofilms in chronic wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[2] Pradeep K. Singh,et al. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. , 2007, The Journal of clinical investigation.
[3] Blaise R. Boles,et al. Self-generated diversity produces "insurance effects" in biofilm communities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] D G Smith,et al. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. , 1999, Diabetes care.
[5] Bernhard Guggenheim,et al. A novel TEM contrasting technique for extracellular polysaccharides in in vitro biofilms , 2007, Microscopy research and technique.
[6] Costerton Jw. Biofilm theory can guide the treatment of device-related orthopaedic infections. , 2005 .
[7] D. Steinberg,et al. Sustained-release delivery systems of triclosan for treatment of Streptococcus mutans biofilm. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.
[8] T. Phan,et al. Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. , 2006, Canadian journal of microbiology.
[9] P. Marsh,et al. The Effects of Triclosan and Zinc Citrate, Alone and in Combination, on a Community of Oral Bacteria Grown in vitro , 1993, Journal of dental research.
[10] D. E. Saye. Recurring and antimicrobial-resistant infections:considering the potential role of biofilms in clinical practice. , 2007, Ostomy/wound management.
[11] K. Harding,et al. Bacteria and wound healing , 2004, Current opinion in infectious diseases.
[12] J. Costerton,et al. Mechanism of persistent infection associated with peritoneal implants. , 1992, Journal of medical microbiology.
[13] J. Pulido,et al. Biofilm and scleral buckle-associated infections. A mechanism for persistence. , 1991, Ophthalmology.
[14] P. Stewart,et al. A microtiter-plate screening method for biofilm disinfection and removal. , 2003, Journal of microbiological methods.
[15] Wagner Fw,et al. The diabetic foot , 1987 .
[16] M. J. Meade,et al. Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. , 2001, FEMS microbiology letters.
[17] Eli N. Perencevich,et al. Health and Economic Impact of Surgical Site Infections Diagnosed after Hospital Discharge , 2003, Emerging infectious diseases.
[18] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[19] L. E. Davis,et al. Biofilm on Ventriculo-Peritoneal Shunt Tubing as a Cause of Treatment Failure in Coccidioidal Meningitis , 2002, Emerging infectious diseases.
[20] D. Bradshaw,et al. Microbial film formation: dental plaque deposition on acrylic tiles using continuous culture techniques. , 1987, The Journal of applied bacteriology.
[21] P. Marsh,et al. Effect of oxygen, inoculum composition and flow rate on development of mixed-culture oral biofilms. , 1996, Microbiology.
[22] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[23] Scot E. Dowd,et al. Windows .NET Network Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST) , 2005, BMC Bioinformatics.
[24] J. Costerton. Biofilm theory can guide the treatment of device-related orthopaedic infections. , 2005, Clinical orthopaedics and related research.
[25] D. Church,et al. Burn Wound Infections , 2006, Clinical Microbiology Reviews.
[26] R. White,et al. Topical antimicrobials in the control of wound bioburden. , 2006, Ostomy/wound management.
[27] M. Gilmore,et al. Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis. , 2002, DNA and cell biology.
[28] S. Percival,et al. Antimicrobial activity of silver‐containing dressings on wound microorganisms using an in vitro biofilm model , 2007, International wound journal.
[29] J. Nickel,et al. Bacterial biofilm in persistent penile prosthesis-associated infection. , 1986, The Journal of urology.
[30] K. Krogfelt,et al. Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[31] J. Costerton. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. , 2001, Trends in microbiology.
[32] T. Møretrø,et al. Evaluation of the antibacterial effect of a triclosan-containing floor used in the food industry. , 2006, Journal of food protection.
[33] K. Beckrich,et al. Hospital-acquired pressure ulcers: a comparison of costs in medical vs. surgical patients. , 1999, Nursing economic$.
[34] S. Malekzadeh,et al. In vivo analysis of bacterial biofilm formation on facial plastic bioimplants , 1998, The Laryngoscope.
[35] A. Widmer,et al. Intravascular catheter-associated infections. , 1997, Schweizerische medizinische Wochenschrift.
[36] D. Stickler,et al. Effect of Triclosan on the Development of Bacterial Biofilms by Urinary Tract Pathogens on Urinary Catheters , 2022 .
[37] K. Krogfelt,et al. Multiple bacterial species reside in chronic wounds: a longitudinal study , 2006, International wound journal.
[38] J. Nickel,et al. Ultrastructural microbial ecology of infection-induced urinary stones. , 1985, The Journal of urology.
[39] G. Onder,et al. Pressure ulcer and mortality in frail elderly people living in community. , 2007, Archives of gerontology and geriatrics.
[40] R. Kirsner,et al. The diabetic foot: The importance of biofilms and wound bed preparation , 2006, Current diabetes reports.